Global Lysosomal Storage Diseases Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Lysosomal Storage Diseases Market Research Report 2024
Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.
According to MRAResearch’s new survey, global Lysosomal Storage Diseases market is projected to reach US$ 10460 million in 2033, increasing from US$ 7436.7 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lysosomal Storage Diseases market research.
According to the report, one driver in the market is unmet medical needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lysosomal Storage Diseases market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Actelion Pharmaceuticals
BioMarin
Genzyme
Takeda
Alexion Pharmaceuticals
Amicus Therapeutics
Chiesi Farmaceutici
Greenovation Biotech And FGK Clinical Research
Horizon Pharma
Leadiant Biosciences
Mylan
Segment by Type
Enzyme Replacement Therapy
Substrate Reduction Therapy
Cystine Depleting Agents
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lysosomal Storage Diseases report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Lysosomal Storage Diseases market is projected to reach US$ 10460 million in 2033, increasing from US$ 7436.7 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lysosomal Storage Diseases market research.
According to the report, one driver in the market is unmet medical needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lysosomal Storage Diseases market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Actelion Pharmaceuticals
BioMarin
Genzyme
Takeda
Alexion Pharmaceuticals
Amicus Therapeutics
Chiesi Farmaceutici
Greenovation Biotech And FGK Clinical Research
Horizon Pharma
Leadiant Biosciences
Mylan
Segment by Type
Enzyme Replacement Therapy
Substrate Reduction Therapy
Cystine Depleting Agents
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lysosomal Storage Diseases report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source